Shuaiqi Huang

Apr 16, 2024 | ahajournals.org | Deborah Kwon |Shuaiqi Huang |Mustafa Turkmani |Donna Salam

CLINICAL PERSPECTIVEComprehensive cardiac magnetic resonance-enriched phenomapping identified 3 distinct ischemic cardiomyopathy phenotypes associated with significant differential risk and response to therapeutic interventions. Quantitative cardiac magnetic resonance evaluation demonstrates marked heterogeneity in infarct characteristics and left ventricle/right ventricle/left atrium remodeling and systolic function to enable more refined prediction of potential survival benefit.

Mar 25, 2024 | resmedjournal.com | Logan Harper |Anoosha Tauquir |Shuaiqi Huang

Due to the heterogeneity of sarcoidosis, there is a need to define clinical phenotypes to allow for tailoring of clinical care and identification of more homogenous populations to facilitate research. We utilized data from a prospectively collected registry of sarcoidosis patients seen at a single quaternary referral center between January 2019 and February 2021.

Mar 4, 2024 | thelancet.com | Dan-Yu Lin |Shuaiqi Huang |Alex Milinovich

1US Food and Drug AdministrationFDA takes action on updated mRNA COVID-19 vaccines to better protect against currently circulating variants.

Sep 21, 2023 | jamanetwork.com | Dan-Yu Lin |Francois Abi Fadel |Shuaiqi Huang

Key PointsQuestion  What outcomes are associated with ritonavir-boosted nirmatrelvir or molnupiravir use for outpatient treatment of SARS-CoV-2 Omicron subvariants, particularly BQ.1.1 and XBB.1.5, in high-risk individuals?